Restore Brain Announces Expansion of Neuromodulation Footprint with New St. Louis Office, Bringing Advanced TMS and SPRAVATO Treatments to the Region

With its expansion into St. Louis, Restore Brain continues its mission to broaden access to advanced psychiatric treatments ...
Pulmonology Advisor

FDA Clears At-Home Neuromodulation Device for Major Depressive Disorder

The FDA clears ProlivRx at-home neuromodulation for adjunctive major depressive disorder treatment in adults with inadequate antidepressant response.
MassDevice

Neurolief gets FDA approval for at-home neuromod that treats depression

Neurolief announced today that the FDA granted approval for its Proliv Rx at-home neuromodulation therapy for treating ...
Medical Dialogues

FDA Approves First At-Home Brain Neuromodulation Device for Depression

The FDA has approved ProlivRx, the first prescription, home-based brain neuromodulation therapy, as an adjunctive treatment ...

First on CNN: Noninvasive brain treatment for depression proves helpful

At Stanford, a treatment that aims magnetic pulses at the brain is showing results for people with treatment-resistant depression. It’s called SAINT, and here’s how it works.
KTLA

Neurolief Announces Publication of Groundbreaking MOOD Study Demonstrating Efficacy of Home or Clinic-Based Neuromodulation Therapy for Major Depressive Disorder

Significant improvement in depressive symptoms among patients using Proliv™Rx compared to sham controls. Favorable safety profile with minimal adverse events. High patient adherence and satisfaction ...
MedPage Today on MSN

FDA approves at-home device for treatment-resistant depression

The FDA approved a prescription at-home brain neuromodulation therapy as an adjunctive depression treatment for adults, maker ...
BioWorld

Neuromodulation for MDD heads home

For individuals with major depressive disorder (MDD) that does not respond to pharmacotherapy, recent decisions by the U.S.

Juniper Biomedical Wins Neuromod Prize and Welcomes Frank Fischer to Board of Directors

The Company also announced that Frank Fischer, founder and chairman of the board of Neuropace and medtech serial entrepreneur, recently joined the Juniper Board of Directors.

Neurolief receives FDA PMA Approval for First At-Home Brain Neuromodulation Therapy for Adults Whose Depression Was Not Adequately Improved by Antidepres…

Neurolief Inc., a medical device company focused on neuromodulation therapies for neuropsychiatric conditions, today ...
The Scientist

The Ear as a Therapeutic Gateway to the Vagus Nerve

Auricular vagal neuromodulation therapy is a non-invasive and non-surgical treatment that could aid cardiovascular disease management, Long COVID relief, and more.
Business Wire

Personalized Neuromodulation Treatment Significantly Slowed Alzheimer’s Progression in 12-month Phase 2 Study, Meeting Primary and Key Secondary Endpoints

Data presented at CTAD showed strong separation from placebo and statistical significance in mild-to-moderate patients on key global, cognitive, and behavioral measures including CDR-SB, ADAS- Cog 11 ...